Roche

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Roche and other ETFs, options, and stocks.

About RHHBY

Roche Holding AG is a research healthcare company. It operates through the Roche Pharmaceuticals and Diagnostics segments.

CEO

Thomas Schinecker

CEOThomas Schinecker

Employees

112,774

Employees112,774

Headquarters

Basel, Basel-Stadt (Basle Town)

HeadquartersBasel, Basel-Stadt (Basle Town)

Founded

1896

Founded1896

Employees

112,774

Employees112,774

RHHBY Key Statistics

Market cap

386.08B

Market cap386.08B

Price-Earnings ratio

23.37

Price-Earnings ratio23.37

Dividend yield

1.75%

Dividend yield1.75%

Average volume

1.34M

Average volume1.34M

High today

$59.21

High today$59.21

Low today

$58.52

Low today$58.52

Open price

$58.58

Open price$58.58

Volume

259.41K

Volume259.41K

52 Week high

$60.85

52 Week high$60.85

52 Week low

$40.07

52 Week low$40.07

RHHBY News

TipRanks 22m

Roche intends to make comeback with oncology pill treatment, Bloomberg says

Roche (RHHBY) Holding intends to make a comeback with giredestrant, an experimental pill developed in-house meant to prevent breast cancer from growing or retur...

TipRanks 1d

Roche upgraded to Outperform from Underperform at Oddo BHF

Oddo BHF analyst Florent Cespedes double upgraded Roche (RHHBY) to Outperform from Underperform with a price target of CHF 440, up from CHF 300. The firm cites...

Benzinga 2d

Swiss Pharma Giant Roche Suspends German Capital Commitments Amid Dispute Over Drug Discounts - Benzinga

...

Analyst ratings

50%

of 24 ratings

Buy

50%

Hold

45.8%

Sell

4.2%

More RHHBY News

TipRanks 2d

Hansoh Pharmaceutical enters collaboration, license agreement with Roche

Hansoh Pharmaceutical Group (HNSPF) announces that it has entered into a strategic collaboration and license agreement with Roche (RHHBY). This agreement marks...

Zacks 5d

Roche Gets FDA Approval for Enspryng in Thyroid Eye Disease

Roche (RHHBY Quick QuoteRHHBY - Free Report) announced that the FDA has approved Enspryng (satralizumab) for the treatment of thyroid eye disease (TED). T...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.